C4 Therapeutics (NASDAQ:CCCC – Get Free Report) is projected to release its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect C4 Therapeutics to post earnings of ($0.1945) per share and revenue of $8.52 million for the quarter. Parties can find conference call details on the company’s upcoming Q3 2026 earnings […]